These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23278679)

  • 21. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D; Kmet V; Niks M
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
    Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH; Chang KT; LaRocco MT; Schilling AN; McCauley SK; Poole K; Garey KW
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):309-14. PubMed ID: 17617302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand.
    Khuntayaporn P; Montakantikul P; Mootsikapun P; Thamlikitkul V; Chomnawang MT
    Ann Clin Microbiol Antimicrob; 2012 Sep; 11():25. PubMed ID: 22970983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible
    Kim N; Ko SY; Park SY; Kim SY; Lee DE; Kwon KT; Kim YK; Lee JC
    Ann Lab Med; 2024 Sep; 44(5):410-417. PubMed ID: 38433574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates.
    Pai H; Kim J; Kim J; Lee JH; Choe KW; Gotoh N
    Antimicrob Agents Chemother; 2001 Feb; 45(2):480-4. PubMed ID: 11158744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter study in Mexican hospitals.
    Garza-Ramos U; Barrios H; Reyna-Flores F; Tamayo-Legorreta E; Catalan-Najera JC; Morfin-Otero R; Rodríguez-Noriega E; Volkow P; Cornejo-Juarez P; González A; Gaytan-Martinez J; Del Rocío Gónzalez-Martínez M; Vazquez-Farias M; Silva-Sanchez J
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):135-7. PubMed ID: 25467172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
    Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
    Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib.
    Tojo M; Tada T; Shimojima M; Tanaka M; Narahara K; Miyoshi-Akiyama T; Kirikae T; Ohmagari N
    J Infect Chemother; 2014 Sep; 20(9):586-8. PubMed ID: 24910373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.